These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17234454

  • 1. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
    Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O.
    Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ, Ratnavel R, Watkins P, Samson D, Apperley J, Ball J, Taylor P, Russell-Jones R.
    Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, Wingard JR.
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1014-21. PubMed ID: 16338624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
    Remberger M, Ringden O, Markling L.
    Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
    [Abstract] [Full Text] [Related]

  • 9. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E, Palangio M, Gonzalez J, Adler KR, Scarborough R, Goldberg SL, Rowley SD.
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J, Taylor P.
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [Abstract] [Full Text] [Related]

  • 15. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
    Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K.
    Transplantation; 2006 May 27; 81(10):1390-7. PubMed ID: 16732175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
    Setterblad N, Garban F, Weigl R, Assier E, Drillat P, Charron D, Dickinson A, Greinix H, Mooney N.
    Transfusion; 2008 Jan 27; 48(1):169-77. PubMed ID: 17900279
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A, Locatelli F, Marmont F, Ceretto C, Falda M.
    Am J Hematol; 2007 Jan 27; 82(1):45-52. PubMed ID: 16937391
    [Abstract] [Full Text] [Related]

  • 19. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.
    J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.